Equillium (EQ) Equity Average (2018 - 2026)
Equillium (EQ) reported Equity Average of $44.0 million for Q1 2026, up 197.19% year-over-year from $14.8 million in Q1 2025, and up 47.95% quarter-over-quarter from $29.8 million in Q4 2025.
Equillium (EQ) Equity Average (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Equity Average data on file, last reported at $44.0 million in Q1 2026.
- Equity Average for Q1 2026 came in at $44.0 million, up 197.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.0 million (up 197.19% YoY), and the FY2025 annual result was $23.8 million, up 14.47% from the prior year.
- Equity Average rose to $44.0 million in Q1 2026 per EQ's latest filing, from $29.8 million in the prior quarter.
- Over five years, Equity Average peaked at $59.6 million in Q1 2022 and troughed at $7.8 million in Q2 2025.
- A 5-year average of $28.2 million and a median of $25.5 million in 2023 frame the typical range for Equity Average.
- The sharpest annual moves came in 2025 and 2026: Equity Average sank 64.08% in 2025, then jumped 197.19% in 2026.
- A 5-year view of Equity Average shows it stood at $30.1 million in 2022, then declined by 22.33% to $23.3 million in 2023, then retreated by 9.52% to $21.1 million in 2024, then soared by 40.95% to $29.8 million in 2025, then jumped by 47.95% to $44.0 million in 2026.
- Business Quant data shows EQ's Equity Average at $44.0 million in Q1 2026, $29.8 million in Q4 2025, and $18.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 44.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.04 Mn |
| Dec 31, 2025 | 29.77 Mn |
| Sep 30, 2025 | 18.00 Mn |
| Jun 30, 2025 | 7.82 Mn |
| Mar 31, 2025 | 14.82 Mn |
| Dec 31, 2024 | 21.12 Mn |
| Sep 30, 2024 | 22.81 Mn |
| Jun 30, 2024 | 21.76 Mn |
| Mar 31, 2024 | 21.83 Mn |
| Dec 31, 2023 | 23.34 Mn |
| Sep 30, 2023 | 25.54 Mn |
| Jun 30, 2023 | 28.13 Mn |
| Mar 31, 2023 | 30.61 Mn |
| Dec 31, 2022 | 30.05 Mn |
| Sep 30, 2022 | 34.21 Mn |
| Jun 30, 2022 | 46.45 Mn |
| Mar 31, 2022 | 59.57 Mn |
| Dec 31, 2021 | 71.15 Mn |
| Sep 30, 2021 | 80.29 Mn |
| Jun 30, 2021 | 88.33 Mn |